Neutrophil Elastase-mediated proteolysis activates the anti-inflammatory cytokine IL-36 Receptor antagonist.
about
Neutrophil plasticity enables the development of pathological microenvironments: implications for cystic fibrosis airway diseaseCorrelation between IL36α and IL17 and Activity of the Disease in Selected Autoimmune Blistering DiseasesInterleukin-36β provides protection against HSV-1 infection, but does not modulate initiation of adaptive immune responsesCathepsin S is the major activator of the psoriasis-associated proinflammatory cytokine IL-36γ.NET Confusion.Estrous Cycle and Gestational Age-Dependent Expression of Members of the Interleukin-36 Subfamily in a Semi-Allogeneic Model of Infected and Non-Infected Murine PregnancyIL-1 and IL-36 are dominant cytokines in generalized pustular psoriasis.Are neutrophilic dermatoses autoinflammatory disorders?Sharpening Host Defenses during Infection: Proteases Cut to the Chase.Mutation in IL36RN impairs the processing and regulatory function of the interleukin-36 receptor antagonist and is associated with DITRA syndrome.IL-36γ has proinflammatory effects on human endothelial cells.Pharmacological Stimulation of Phagocytosis Enhances Amyloid Plaque Clearance; Evidence from a Transgenic Mouse Model of ATTR Neuropathy.Evaluation of a range of mammalian and mosquito cell lines for use in Chikungunya virus research.Regulation and function of interleukin-36 cytokines.Suppressing IL-36-driven inflammation using peptide pseudosubstrates for neutrophil proteases.IL-36γ Is a Strong Inducer of IL-23 in Psoriatic Cells and Activates Angiogenesis.Identification of small-molecule elastase inhibitors as antagonists of IL-36 cytokine activation.
P2860
Q28071357-21C18931-08F8-480A-B08A-5745702FCA27Q33762424-17CBDE3F-10EA-45C6-A292-2E72A26CC8ECQ33918535-ADD8EC28-E776-4524-AF98-FAB09985AA76Q34553191-BF6FDCC1-1D93-4383-9C7A-AFCF785F5956Q37043270-2C11187F-97F1-4D67-AB7B-E032C843F49EQ37273577-4C7B92E5-D561-4F77-8F03-7F220ABD41EDQ38438511-41ECE7DF-9A01-4CDF-8FDA-C37ABA74646CQ39025288-67EF2CA9-3F02-4E84-A4F8-9691C65DA539Q39127087-72741BCD-6A7F-4DCC-A3C1-8424EA941668Q40176830-136746DE-6317-40BA-B8C9-812F5E17AA30Q40526106-5632670F-9A66-4E16-AE4C-B23FBA840B2BQ41868481-A8105D33-836E-46A9-9E75-3E1C3FB01B46Q44169670-C66FF9BB-F71C-4546-8E41-E09294075F9CQ47298022-252EC6D5-AC1A-4288-A1ED-0DE097292DF0Q52728096-88DD416F-8A97-4473-B76A-A80FD86935E7Q52802857-34E7AFA3-B4FC-475F-9EF8-6C46E7B24714Q55111930-054F408F-914A-4AFE-92E9-34295F06310C
P2860
Neutrophil Elastase-mediated proteolysis activates the anti-inflammatory cytokine IL-36 Receptor antagonist.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Neutrophil Elastase-mediated p ...... ine IL-36 Receptor antagonist.
@en
Neutrophil Elastase-mediated p ...... ine IL-36 Receptor antagonist.
@en-gb
type
label
Neutrophil Elastase-mediated p ...... ine IL-36 Receptor antagonist.
@en
Neutrophil Elastase-mediated p ...... ine IL-36 Receptor antagonist.
@en-gb
prefLabel
Neutrophil Elastase-mediated p ...... ine IL-36 Receptor antagonist.
@en
Neutrophil Elastase-mediated p ...... ine IL-36 Receptor antagonist.
@en-gb
P2093
P2860
P50
P356
P1154
2-s2.0-84964277318
P1433
P1476
Neutrophil Elastase-mediated p ...... ine IL-36 Receptor antagonist.
@en
P2093
Adewonuola Alase
Martin Stacey
Miriam Wittmann
Rosella Doble
P2860
P2888
P356
10.1038/SREP24880
P407
P5530
P577
2016-04-22T00:00:00Z
P6179
1000209612